Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles.
暂无分享,去创建一个
Samuel Achilefu | Walter J Akers | Samuel A Wickline | Gregory M Lanza | Yunpeng Ye | Kevin Guo | S. Achilefu | M. Berezin | S. Wickline | G. Lanza | R. Fuhrhop | Y. Ye | W. Akers | Kevin Guo | Anthony Agee | Zongren Zhang | Ralph W Fuhrhop | Mikhail Berezin | Anthony Agee | Zongren Zhang
[1] Sharon Bloch,et al. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. , 2006, Journal of medicinal chemistry.
[2] Kerry K. Karukstis,et al. Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.
[3] A. Sinusas,et al. Detection of Injury-Induced Vascular Remodeling by Targeting Activated &agr;vβ3 Integrin In Vivo , 2004 .
[4] Z. Fayad,et al. Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots , 2008, Angiogenesis.
[5] A. Beer,et al. Application of RGD-containing peptides as imaging probes for alphavbeta3 expression. , 2009, Frontiers in bioscience.
[6] Samuel Achilefu,et al. Monitoring the biodegradation of dendritic near-infrared nanoprobes by in vivo fluorescence imaging. , 2008, Molecular pharmaceutics.
[7] H. Kessler,et al. Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting. , 2006, Current pharmaceutical design.
[8] Michael Scott,et al. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics , 2007, International journal of nanomedicine.
[9] B Chance,et al. Metabolism-enhanced tumor localization by fluorescence imaging: in vivo animal studies. , 2003, Optics letters.
[10] P. Lin,et al. Nanotechnology for antiangiogenic cancer therapy. , 2006, Nanomedicine.
[11] Kathryn E. Luker,et al. Optical Imaging: Current Applications and Future Directions , 2007, Journal of Nuclear Medicine.
[12] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .
[13] Werner Jaschke,et al. Molecular imaging with nanoparticles: giant roles for dwarf actors , 2008, Histochemistry and Cell Biology.
[14] Yunpeng Ye,et al. Synthesis and characterization of a macrocyclic near-infrared optical scaffold. , 2003, Journal of the American Chemical Society.
[15] S. Caruthers,et al. High Sensitivity: High-Resolution SPECT-CT/MR Molecular Imaging of Angiogenesis in the Vx2 Model , 2009, Investigative radiology.
[16] Weibo Cai,et al. Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.
[17] M. Neeman,et al. Molecular imaging of angiogenesis , 2007, Journal of magnetic resonance imaging : JMRI.
[18] S. Caruthers,et al. Three‐dimensional MR mapping of angiogenesis with α5β1(αvβ3)‐targeted theranostic nanoparticles in the MDA‐MB‐435 xenograft mouse model , 2008, The FASEB Journal.
[19] Samuel A Wickline,et al. Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery. , 2005, Ultrasound in medicine & biology.
[20] Samuel A. Wickline,et al. Endothelial &agr;&ngr;&bgr;3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis , 2006 .
[21] S. Caruthers,et al. Minute dosages of ανβ3‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbits , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] Grace Hu,et al. Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.
[23] S. Achilefu,et al. Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. , 2000, Investigative radiology.
[24] P. Choyke,et al. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.
[25] P. Schlesinger,et al. Synthesis and Characterization of Stable Fluorocarbon Nanostructures as Drug Delivery Vehicles for Cytolytic Peptides , 2008 .
[26] Stasia A. Anderson,et al. Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .
[27] D. Sept,et al. Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging , 2008, Magnetic resonance in medicine.
[28] D. Dione,et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. , 2004, The Journal of clinical investigation.
[29] S. Achilefu,et al. Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a Radionuclide , 2009, Molecular imaging.
[30] Garry E. Kiefer,et al. Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles , 2007 .
[31] Jonathan R Lindner,et al. Molecular imaging with targeted contrast ultrasound. , 2007, Current opinion in biotechnology.